Maria A. Antor

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 127 citations · Full text

Long Covid, Clinical Therapeutic, Covid-19 Pandemic +6

Clinical and economic outcomes of low‐field intraoperative MRI‐guided tumor resection neurosurgery

Mina S. Makary, E. Antonio Chiocca, Natali Erminy et al. · Journal of Magnetic Resonance Imaging · 2011 · 61 citations · Full text

A Prospective, Randomized, Double-Blinded, Double-Dummy Pilot Study to Assess the Preemptive Effect of Triple Therapy with Aprepitant, Dexamethasone, and Promethazine versus Ondansetron, Dexamethasone, and Promethazine on Reducing the Incidence of Postoper

Sergio D. Bergese, Erika Puente-Poushnejad, Maria A. Antor et al. · Frontiers in Medicine · 2016 · 24 citations · Full text

Desflurane Allows for a Faster Emergence When Compared to Sevoflurane without Affecting the Baseline Cognitive Recovery Time

Joseph Werner, Karina Castellón-Larios, Cattleya Thongrong et al. · Frontiers in Medicine · 2015 · 19 citations · Full text

Triple Therapy with Scopolamine, Ondansetron, and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Moderate to High-Risk Patients Undergoing Craniotomy Under General Anesthesia: A Pilot Study

Sergio D. Bergese, Maria A. Antor, Alberto Uribe et al. · Frontiers in Medicine · 2015 · 16 citations · Full text